HIV drug fails to prevent COVID in High-Risk healthcare workers
Prevention
Terminated
This study tested whether a daily pill (TAF/FTC), normally used for HIV, could prevent COVID-19 in healthcare workers at high risk of exposure. About 1,378 participants were randomly assigned to receive the drug or a placebo. The trial was terminated early, and the results did no…
Phase: PHASE3 • Sponsor: Hospital Italiano de Buenos Aires • Aim: Prevention
Last updated May 15, 2026 11:53 UTC